Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
615 participants
INTERVENTIONAL
2004-06-30
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
aripiprazole
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otsuka America Pharmaceutical
INDUSTRY
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Bristol-Myers Squibb
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Local Institution
Tuscaloosa, Alabama, United States
Local Institution
Scottsdale, Arizona, United States
Local Institution
Cerritos, California, United States
Local Institution
Garden Grove, California, United States
Local Institution
La Palma, California, United States
Local Institution
Riverside, California, United States
Local Institution
San Diego, California, United States
Local Institution
Denver, Colorado, United States
Local Institution
Middletown, Connecticut, United States
Local Institution
New Haven, Connecticut, United States
Local Institution
Bradenton, Florida, United States
Local Institution
Kissimmee, Florida, United States
Local Institution
Maitland, Florida, United States
Local Institution
Augusta, Georgia, United States
Local Institution
Honolulu, Hawaii, United States
Local Institution
Chicago, Illinois, United States
Local Institution
Hoffman Estates, Illinois, United States
Local Institution
Indianapolis, Indiana, United States
Local Institution
Louisville, Kentucky, United States
Local Institution
New Orleans, Louisiana, United States
Local Institition
Shreveport, Louisiana, United States
Local Institution
Saint Charles, Missouri, United States
Local Institution
Clementon, New Jersey, United States
Local Institution
Cedarhurst, New York, United States
Local Institution
Elmsford, New York, United States
Local Institution
Holliswood, New York, United States
Local Institution
Morganton, North Carolina, United States
Local Institution
Raleigh, North Carolina, United States
Local Institution
Cincinnati, Ohio, United States
Local Institution
Cleveland, Ohio, United States
Local Institution
Lyndhurst, Ohio, United States
Local Institution
Oklahoma City, Oklahoma, United States
Local Institution
Norristown, Pennsylvania, United States
Local Institution
Philadelphia, Pennsylvania, United States
Local Institution
Austin, Texas, United States
Local Institution
Bellaire, Texas, United States
Local Institution
Houston, Texas, United States
Local Institution
Arlington, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, McQuade RD, Carson WH; CN138-135 Study Group. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study. J Affect Disord. 2009 Jan;112(1-3):36-49. doi: 10.1016/j.jad.2008.05.014. Epub 2008 Oct 2.
McIntyre RS, McElroy SL, Eudicone JM, Forbes RA, Carlson BX, Baker RA. A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder. Prim Care Companion CNS Disord. 2011;13(6):PCC.11m01182. doi: 10.4088/PCC.11m01182.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CN138-135
Identifier Type: -
Identifier Source: org_study_id